PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients
Thibault Gauduchon, Maria Kfoury, Domenica Lorusso, Anne Floquet, Jole Ventriglia, Hélène Salaün, Malak Moubarak, Romain Rivoirard, Laura Polastro, Laure Favier, Benoît You, Dominique Berton, Thibault De La Motte Rouge, Laura Mansi, Cyril Abdeddaim, Karine Prulhière, Laurence Lecomte, Magali Provansal, Cécile Dalban, I. L. Ray-Coquard
Topics & Concepts
MedicineOvarian cancerOncologyPoly ADP ribose polymeraseInternal medicineCancerCancer researchPolymeraseBiochemistryGeneChemistryPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentLung Cancer Research Studies